| abstract |
A method for investigating whether a subject, particularly a human subject, is at risk of developing, having, or experiencing a complication of cardiovascular disease has been found to be at risk for cardiovascular disease by current methods A method of treating a subject is provided. In one embodiment, the method includes measuring the level of one or more oxidized apolipoprotein AI-related biomolecules in a sample from the subject's body. Furthermore, kits and reagents for use in the present methods are provided. Further provided are methods for monitoring the state of cardiovascular disease in a subject and the effect of a therapeutic agent on a subject having cardiovascular disease. Such methods include measuring the level of one or more oxidized apolipoprotein AI related molecules in a body-derived sample taken from a subject over time or before and after treatment. |